MARKI L HALL

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant ALCOA, TN NPI 1770109555

General Payments — all program years on this page

$440.81

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 25
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $363.33 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $363.3320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $77.485
2024 $363.3320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078180925 Janssen Pharmaceuticals, Inc $16.74 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078180933 Janssen Pharmaceuticals, Inc $16.00 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100254722 Novo Nordisk Inc $22.27 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100285058 Novo Nordisk Inc $21.41 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100358918 Novo Nordisk Inc $15.09 07/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100499641 Novo Nordisk Inc $19.66 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104204133 AstraZeneca Pharmaceuticals LP $13.76 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104232925 AstraZeneca Pharmaceuticals LP $14.99 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104298228 AstraZeneca Pharmaceuticals LP $18.01 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105729131 AstraZeneca Pharmaceuticals LP $14.99 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105811999 AstraZeneca Pharmaceuticals LP $17.57 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107276420 ABBVIE INC. $23.37 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107276422 ABBVIE INC. $24.27 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107276424 ABBVIE INC. $24.26 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117571527 Amgen Inc. $13.80 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118146112 Boehringer Ingelheim Pharmaceuticals, Inc. $15.64 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135755833 Lilly USA, LLC $16.12 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139535972 Astellas Pharma US Inc $17.20 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141969979 Merck Sharp & Dohme LLC $19.58 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144634261 Xeris Pharmaceuticals, Inc. $18.60 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.